Groups
Ahmed A, Ali Y, Elduma A, Eldigail M H, Mhmoud R A, Mohamed N S, Ksiazek T G, Dietrich I, Weaver S C (2020)
Unique Outbreak of Rift Valley Fever in Sudan, 2019
Emerging Infectious Diseases 26 (12) , 3030-3033
Publisher’s version: https://doi.org/10.3201/eid2612.201599
Ahmed A, Eldigail M, Elduma A, Breima T, Dietrich I, Ali Y, Weaver S C (2021)
First report of epidemic dengue fever and malaria co-infections among internally displaced persons in humanitarian camps of North Darfur, Sudan
International Journal of Infectious Diseases 108 , 513-516
Publisher’s version: https://doi.org/10.1016/j.ijid.2021.05.052
Conceicao C, Thakur N, Human S, Kelly J T, Logan L, Bialy D, Bhat S, Stevenson-Leggett P, Zagrajek A K, Hollinghurst P, Varga M, Tsirigoti C, Hammond J A, Maier H J, Bickerton E, Shelton H, Dietrich I, Graham S C, Bailey D (2020)
The SARS-CoV-2 spike protein has a broad tropism for mammalian ACE2 proteins
PLOS Biology 18 (12) , e3001016
Publisher’s version: https://doi.org/10.1371/journal.pbio.3001016
Tan T K, Rijal P, Rahikainen R, Keeble A H, Schimanski L, Hussain S, Harvey R, Hayes J W P, Edwards J C, McLean R K, Martini V, Pedrera M, Thakur N, Conceicao C, Dietrich I, Shelton H, Ludi A, Wilsden G, Browning C, Zagrajek A K, Bialy D, Bhat S, Stevenson-Leggett P, Hollinghurst P, Tully M, Moffat K, Chiu C, Waters R, Gray A, Azhar M, Mioulet V, Newman J, Asfor A S, Burman A, Crossley S, Hammond J A, Tchilian E, Charleston B, Bailey D, Tuthill T J, Graham S P, Duyvesteyn H M E, Malinauskas T, Huo J, Tree J A, Buttigieg K R, Owens R J, Carroll M W, Daniels R S, McCauley J W, Stuart D I, Huang K A, Howarth M, Townsend A R (2021)
A COVID-19 vaccine candidate using SpyCatcher multimerization of the SARS-CoV-2 spike protein receptor-binding domain induces potent neutralising antibody responses
Nature Communications 12 , 542
Publisher’s version: https://doi.org/10.1038/s41467-020-20654-7
Folegatti P M, Ewer K J, Aley P K, Angus B, Becker S, Belij-Rammerstorfer S, Bellamy D, Bibi S, Bittaye M, Clutterbuck E A, Dold C, Faust S N, Finn A, Flaxman A L, Hallis B, Heath P, Jenkin D, Lazarus R, Makinson R, Minassian A M, Pollock K M, Ramasamy M, Robinson H, Snape M, Tarrant R, Voysey M, Green C, Douglas A D, Hill A V S, Lambe T, Gilbert S C, Pollard A J, on behalf of Oxford COVID Vaccine Trial Group (2020)
Safety and immunogenicity of the ChAdOx1 nCoV-19 vaccine against SARS-CoV-2: a preliminary report of a phase 1/2, single-blind, randomised controlled trial
The Lancet 396 (10249) , 467-478
Publisher’s version: https://doi.org/10.1016/S0140-6736(20)31604-4
Pages
ABCD and Merial Young Scientist of the Year Award (2011)